Natera and TransCode team up on colorectal cancer MRD trial
Natera, Inc. (Nasdaq: NTRA) and TransCode Therapeutics, Inc. (Nasdaq: RNAZ) have announced a collaboration to support patient enrollment in TransCode's ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

